failure to respond or late response
on 27 Dec 2008
Last Applicant/ Owned by
600 Peter Morand Cresent., Suite 300
Ottawa Ontario KlG 523
CA
Serial Number
75857872 filed on 19th Nov 1999
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
Applicant claims color as a feature of the mark.
PHARMACEUTICAL PREPARATIONS, ANTIVIRALS, DRUG DELIVERY BIOSYSTEMS, DRUG TESTING PRODUCTS, NAMELY, MEDICAL DIAGNOSTIC REAGENTS, AND DIAGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR MEDICAL OR LABORATORY USE, ALL OF THE ABOVE FOR THE USE IN THE TREATMENT OF CANCER, GENDER AND SEXUALLY TRANSMITTED DISEASES, IMMUNE-RELATED DISORDERS AND IMMUNE-RELATED ILLNESSES AND ANTIBIOTIC RESISTANCE DIAGNOSTIC TESTRead More
PHARMACEUTICAL PREPARATIONS, ANTIVIRALS, DRUG DELIVERY BIOSYSTEMS, DRUG TESTING PRODUCTS, NAMELY, MEDICAL DIAGNOSTIC REAGENTS, AND DIAGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR MEDICAL OR LABORATORY USE, ALL OF THE ABOVE FOR THE USE IN THE TREATMENT OF CANCER, GENDER AND SEXUALLY TRANSMITTED DISEASES, IMMUNE-RELATED DISORDERS AND IMMUNE-RELATED ILLNESSES AND ANTIBIOTIC RESISTANCE
DIAGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR SCIENTIFIC OR RESEARCH USE IN THE AREAS OF CANCER, GENDER AND SEXUALLY TRANSMITTED DISEASES, IMMUNE-RELATED DISORDERS AND IMMUNE-MODULATION, NEURODEGENERATIVE DISEASES, AGE-RELATED ILLNESSES, ANTIVIRAL AND ANTIBIOTIC RESISTANCE RESEARCH
LABORATORY ROBOTIC SYSTEMS, NAMELY, LABORATORY INSTRUMENTS AND VIALS USED TO ANALYZE AND PREPARE COMPOUNDS IN THE FIELDS OF CANCER, GENDER AND SEXUALLY TRANSMITTED DISEASES, IMMUNE-RELATED DISORDERS AND IMMUNE-MODULATION, NEURODEGENERATIVE DISEASES, AGE-RELATED ILLNESSES, ANTIVIRAL AND ANTIBIOTIC RESISTANCE RESEARCH
TESTING OF NEW DRUGS FOR OTHERS, MEDICAL SERVICES, NAMELY, DIAGNOSIS TREATMENT AND RESEARCH SERVICES, DEVELOPMENT OF ROBOTIC SYSTEMS TO ANALYZE AND PREPARE COMPOUNDS, RESEARCH AND DEVELOPMENT RELATING TO AUTOMATIZED BIOLOGICAL DIAGNOSTIC ASSAYS USING ROBOTIC SYSTEMS, MEDICAL INFORMATION SERVICES, NAMELY, DATA GATHERING, PROCESSING, ACQUISITION AND MANAGEMENT, ALL OF THE ABOVE FOR USE IN THE TREATMENT OF CANCER, GENDER AND SEXUALLY TRANSMITTED DISEASES, IMMUNE-RELATED DISORDERS AND IMMUNO MODULATION NEURODEGENERATIVE DISEASES, AGE RELATED ILLNESSES, ANTIVIRALS AND ANTIBIOTIC RESISTANCES
No 75857872
No Service Mark
No 270.45US01
No
No
No
No
No
No
No
No
01.11.02 -
Partial moons, including half moons and crescent moons
26.01.21 -
Circles that are totally or partially shaded
26.03.03 -
Incomplete ovals
26.03.04 -
Ovals with two breaks or divided in the middle
26.07.13 -
Two diamonds
| Status Date | Action Taken |
|---|---|
| 29th Dec 2008 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 27th Dec 2008 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 29th May 2008 | INQUIRY AS TO SUSPENSION MAILED |
| 28th May 2008 | SUSPENSION INQUIRY WRITTEN |
| 03rd Apr 2008 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| 03rd Oct 2007 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 29th Mar 2007 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 29th Mar 2007 | ASSIGNED TO LIE |
| 11th Sep 2006 | SUSPENSION LETTER WRITTEN |
| 08th Sep 2006 | AMENDMENT FROM APPLICANT ENTERED |
